åæ¥æ®µéã®å»è¬åäŒç€Ÿã§ãã Jaguar Health, Inc. ã¯ãæ¶å管é害ãç¹ã«æ
¢æ§ã§è¡°åŒ±æ§ã®äžç¢ã«èŠãã人ãåç©ã®ããã®åŠæ¹è¬ã®éçºã«éç¹ã眮ããŠããŸããå瀟ã¯ã人éã®å¥åº·ãšåç©ã®å¥åº·ãšãã 2 ã€ã®å ±åã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸããå瀟ã¯ãåäŒç€Ÿã® Napo Pharmaceuticals, Inc. ãéããŠãç±åž¯éšæå°åãã責任ãæã£ãŠåç©«ãããæ€ç©ããç¬èªã®æ€ç©ããŒã¹ã®äººéã®æ¶å管å»è¬åã®éçºãšåååã«éç¹ã眮ããŠããŸããå瀟ã¯ãæã¬ãããŠã€ã«ã¹çæ³äžã® HIV/AIDS ã®æäººã®éæææ§äžç¢ã®çç¶ç·©åãç®çãšããã¯ããã§ã¬ã㌠125 mg ã®é
å»¶æŸåºé Mytesi ã販売ããŠããŸããå瀟ã¯ãæšççæ²»çã«é¢é£ããäžç¢ãå
倩æ§äžç¢æ§çŸæ£ããã³çè
žçå矀ã®ä¹³å
ããã³å°å
ã«å¯Ÿããåžå°çŸç
çšå»è¬åã®é©å¿ãççæ§è
žçŸæ£ã®æ¯æçæ³ãéææ§è
žçå矀ãªã©ãè€æ°ã®å¯èœæ§ã®ããåŸç¶ã®é©å¿çã«ã€ã㊠Mytesi ãéçºããŠããŸãããŸããç¹çºæ§/æ©èœæ§äžç¢ã«å¯Ÿããæ²»çè¬ãéçºäžã§ãããã³ã¬ã©ã«å¯Ÿãã第 2 äžä»£ã®ç¬èªã®åæ³æå¶å€ãéçºäžã§ããå瀟ã¯ãŸããç¬ã®ååŠçæ³èªçºæ§äžç¢ã«å¯Ÿããå»è¬ååè£ã§ããã¯ããã§ã¬ããŒãéçºããŠããŸãããžã£ã¬ãŒ ãã«ã¹ç€Ÿã¯ 2013 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã